Atacand (candesartan), a new angiotensin II receptor blocker (ARB) for hypertension

November 1998

Astra is now promoting Atacand (candesartan), a new angiotensin II receptor blocker (ARB) for hypertension.

It's the fourth drug in this class...along with Cozaar (losartan), Diovan (valsartan), and Avapro (irbesartan).

These drugs block angiotensin II...a potent vasoconstrictor.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote